Diagnostic value of endobronchial ultrasonography for pulmonary tuberculosis  by Lin, Shu-Min et al.
PERIOPERATIVE MANAGEMENTDiagnostic value of endobronchial ultrasonography for pulmonary
tuberculosis
Shu-Min Lin, MD, Fu-Tsai Chung, MD, Chien-Da Huang, MD, Wen-Te Liu, MD, Chih-Hsia Kuo, MD,
Chun-Hua Wang, MD, Kang-Yun Lee, MD, PhD, Chien-Ying Liu, MD, Horng-Chyuan Lin, MD,
and Han-Pin Kuo, MD, PhD
Objectives:We sought to compare the diagnostic yields of acid-fast bacilli smears andMycobacterium tubercu-
losis cultures in terms of bronchoalveolar lavage fluid and histologic examination of transbronchial lung biopsy
specimens for pulmonary tuberculosis by using bronchoscopy with versus without endobronchial ultrasonogra-
phy in patients with negative acid-fast bacilli smears or no sputum production.
Methods: From June 2005 to July 2006, a total of 451 patients were given diagnoses of and treated for pulmonary
tuberculosis in a university-affiliated hospital. Among them, 121 patients who received bronchoscopy because of
sputum-negative conditions were recruited. Of these, 73 patients received bronchoscopy with endobronchial ul-
trasonography, and 48 patients received conventional bronchoscopy.
Results: Patients who received bronchoscopy with endobronchial ultrasonography had higher diagnostic yields of
acid-fast bacilli smears (31.5% vs 12.5%, P¼ .018) in bronchoalveolar lavage fluid,M tuberculosis in bronchoal-
veolar lavage fluid (67.1% vs 47.9%, P ¼ .024), and pathologic reports of tuberculosis in transbronchial lung
biopsy specimens (32.9% vs 4.2%, P< .0001) than patients who received conventional bronchoscopy. With
the aid of endobronchial ultrasonography, the overall diagnostic yield for tuberculosis by using bronchoscopic pro-
cedures (smears and cultures of bronchoalveolar lavage fluid and transbronchial lung biopsy specimens) was higher
(80.8%) than for those who did not undergo endobronchial ultrasonography (58.3%, P ¼ .035).
Conclusions: The addition of endobronchial ultrasonography to diagnostic bronchoscopy increased the sensitiv-
ity for proving the presence of tuberculosis in a population of patients with negative acid-fast bacilli smears or no
sputum production.P
MTuberculosis is the leading infectious cause of death among
persons older than 5 years, particularly in Southeast Asia
and sub-Saharan Africa.1 In the United States the incidence
of tuberculosismore than doubled during the 1980s.2 Sputum
examination is the most useful method for diagnosing active
pulmonary tuberculosis. However, about half of the patients
suspected of active pulmonary tuberculosis are unable to pro-
duce sputum.3 Even if sputum is available, acid-fast bacilli
(AFB) might not be found on repeated examination of direct
smears.4 Therefore the condition of a negative sputum smear
and no sputum production is one of the causes of delay in tu-
berculosis diagnosis. Delays in diagnosis and treatment have
been recognized as an important cause of death from pulmo-
nary tuberculosis.2,5 Patients might be left untreated until
Mycobacterium tuberculosis grows from the culture speci-
mens. Untreated patients with pulmonary tuberculosis can
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in the community. Possible approaches to deal with this con-
dition include empiric treatment with antituberculosis me-
dications, close follow-up of the progression of chest
radiographic lesions for 6 to 8weekswhilewaiting for culture
results, and alternative methods for obtaining lower respira-
tory tract specimens.4,6 However, the first 2 approaches
might delay the true diagnosis. In contrast, invasive proce-
dures, such as percutaneous lung biopsy, carry the potential
risk for hemorrhage and pneumothorax, which are especially
hazardous in patients with poor lung reserves. Thus bron-
choscopy can be used in this condition to provide the clue
for earlier diagnosis of tuberculosis or to obtain specimens
in patients without spontaneous sputum.
Bronchoscopy with AFB smears and cultures forM tuber-
culosis of bronchoalveolar lavage fluid (BALF) and histo-
logic examination of transbronchial lung biopsy (TBLB)
specimens have been introduced to reach an early bacterio-
logic diagnosis of tuberculosis in sputum-negative patients
or patients unable to expectorate, with varying results.3,6-8
Endobronchial ultrasonography (EBUS), a newly introduced
technique, has been applied to the assessment of peripheral
lung lesions.9,10Comparedwith conventional bronchoscopy,
EBUS offers the benefits of visualizing the parabronchial
structure, confirming the precise location of peripheral lung
lesions and therefore improving the diagnostic yield.11,12
By means of demonstration of a good correlation betweenardiovascular Surgery c Volume 138, Number 1 179
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CT ¼ computed tomography
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EBUS images and histology of lung lesions, the characteris-
tics of EBUS images also provide useful clues in differenti-
ating malignant and benign lesions in the peripheral lung.11
However, the role of bronchoscopy with the aid of EBUS in
the diagnosis of pulmonary tuberculosis is still unclear.
The primary aim of this study was to compare the diag-
nostic yields of AFB smears, M tuberculosis cultures in
BALF, and histologic examination of TBLB specimens for
pulmonary tuberculosis by using bronchoscopy with or
without EBUS in patients with negative AFB smears or no
sputum production. The secondary aim was to determine
the contributions of EBUS-guided procedures on early diag-
nosis of pulmonary tuberculosis.
MATERIALS AND METHODS
Study Subjects
The study retrospectively analyzed patients who underwent bronchos-
copy at Chang Gung Memorial Hospital, a university-affiliated, 3300-bed
hospital in Taiwan. From June 2005 to July 2006, a total 451 patients
were given diagnoses of and treated for pulmonary tuberculosis in the hos-
pital. Among them, 121 patients received bronchoscopy because of a lack of
spontaneous sputum or negative AFB smears in 3 consecutive daily sputum
specimens. Of these, 73 who received bronchoscopic examination with
EBUS guidance were defined as the EBUS group. The other 48 patients un-
derwent bronchoscopic examinations during the time period when EBUS
was not available. They received bronchoscopic examination without
EBUS guidance and were designated as the non-EBUS group. All the pa-
tients received bronchoscopy-related procedures for the diagnosis of active
pulmonary tuberculosis, including AFB smears and cultures for M tuber-
culosis from BALF and histologic examination of TBLB specimens. No
patients were infected with HIV. All patients then provided written in-
formed consent to undergo bronchoscopy. This study was approved by
the hospital’s internal review board. Patients’ baseline characteristics in-
cluded age, sex, location and size of lesion, and radiologic appearance. Un-
derlying medical history was also collected, including histories of diabetes
mellitus, hypertension, malignancy, chronic airway obstruction disease, and
previous tuberculosis infection.
Bronchoscopic Procedures and Equipment
The patients were referred to the institutional bronchoscopic center for
procedures. The bronchoscopic examinations were performed by 2 experi-
enced independent bronchoscopists (S. M. Lin and F. T. Chung), each of
whom had performed more than 200 bronchoscopic procedures each year.
The EBUS group was retrieved after each of the bronchoscopists had per-
formed more than 50 EBUS procedures to ensure the quality of EBUS in
the study. The probable location of the lesion was determined initially by
using traditional posterior anterior chest radiography with or without chest
computed tomography (CT). Both groups had similar percentages of pa-
tients who received a CT scan before bronchoscopy (EBUS vs non-
EBUS, 27/73 [37%] vs 20/48 [41.7%], respectively; P ¼ .704). A flexible
fiberoptic bronchoscope (BF-P240 or BF-40; Olympus, Tokyo, Japan) was180 The Journal of Thoracic and Cardiovascular Suthen inserted through the nostril after local spray of 2% lidocaine for anes-
thesia. The heart rate and oxygen saturation of each patient were monitored
by using a pulse oximeter during the procedure. In the EBUS group a 20-
MHz, radial, mechanical-type ultrasonographic probe (model UM-S20-
S20R, Olympus) and an ultrasound unit (Endoscopic Ultrasound System,
Olympus) were used in the procedure. The EBUS catheter was advanced
into the fourth- to sixth-order bronchi to assess lesions in the periphery of
the lung. Once the lesion was located by using EBUS, the neighbor bronchi-
olar orifices were also examined to ensure the precise location of lesions.
Each EBUS image was evaluated for 3 features, including the continuous
margin of the lesion, the presence of an air bronchogram, and the heteroge-
neous echogenicity of the internal structure.11 The EBUS procedure was
performed without a guide sheath.
Bronchoalveolar lavage was performed by means of infusion of 6 ali-
quots of 50 mL of normal saline, and the TBLB specimen was taken
last.13 The return was submitted for AFB smear and culture. Lavaged spec-
imens were processed with standard methodology and stained with fluoro-
chrome.14 Positive smears were confirmed by means of Ziehl–Neelsen
staining. Specimens were cultured with a Bactec 12B vial (radiometric Bac-
tec 460-TB system; Becton Dickinson, Franklin Lakes, NJ) and Lowen-
stein–Jensen media (Bio-Rad, Marnesla-Coquette, France). TBLB was
performed for lung parenchyma biopsy specimens. At least 3 pieces of tis-
sue specimens were obtained by means of TBLB. The specimens were
placed in 10% buffered formaldehyde solution and subsequently examined
with hematoxylin and eosin and Ziehl–Neelsen staining. The overall mean
time for the procedure was 10.5 2.1 minutes for the EBUS group and 9.3
 2.3 minutes for the non-EBUS group.
Diagnosis of Pulmonary Tuberculosis
In patients who are suspected of having tuberculosis for radiologic rea-
sons, the diagnosis of tuberculosis was made based on positive M tubercu-
losis cultures in specimens or histologic demonstration of granulomatous
inflammation with Langham’s giant cells and caseation. The final diagnosis
of active pulmonary tuberculosis was reconfirmed based on consensus be-
tween at least 2 respiratory specialists after at least 3 months of patient fol-
low-up. Ambiguities were resolved by means of independent review with
another chest physician or radiologist. Patients with a positive AFB smear
in BALF but a negative result on M tuberculosis culture were excluded
(n ¼ 2).
Statistical Analysis
Data are expressed as either group percentages (categorical variables) or
means  standard deviations (continuous variables). Data were compared
between the EBUS and non-EBUS groups. Categorical variables were com-
pared by using the c2 test (or the Fisher’s exact test when the expected num-
ber of any cells was 5). We applied the t test to compare continuous
variables with normal distribution and the Mann–Whitney test for continu-
ous variables not distributed normally. All analyses were performed with
SPSS software version 10.0 (SPSS, Inc, Chicago, Ill).
RESULTS
Baselines
The baseline characteristics of the enrolled patients are
summarized in Table 1. There were no significant differences
between groups regarding demographic variables, size of the
lesion, location of the lesion, radiologic appearance, and
chronic comorbidities. For the EBUS group, 61 (83.6%) of
73 lesions were localized by means of EBUS. The presence
of an air bronchogram was observed in 54 (74%) of 73 pa-
tients; lesions with continuous margins and homogenous
echogenicity were detected in 41 (56.1%) of 73 and 53rgery c July 2009
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Baseline characteristics Without EBUS (n ¼ 48) With EBUS (n ¼ 73) P value
Age (y), mean  SD 48.5  22.8 56.0  14.5 .103
Female sex 22 (45.3%) 22 (30.1%) .086
Size of lesion (cm), mean  SD 3.4  1.4 3.8  1.6 .225
Lesion size<3 cm 22 (45.3%) 31 (42.5%) .852
Lesion localized by EBUS NA 61 (83.6%) NA
Lesion (<3 cm) localized by EBUS NA 23 (74.2%) NA
Location of lesion
Right upper lobe 22 (45.3%) 24 (32.9%) .182
Right middle lobe 4 (8.4%) 11 (15.1%) .399
Right lower lobe 0 (0%) 2 (2.7%) .278
Left upper lobe 18 (37.5%) 20 (27.4%) .317
Left lower lobe 4 (8.4%) 16 (21.9%) .078
Radiologic appearance
With cavity 6 (12.5%) 10 (13.7%) 1.00
With lymphadenopathy 7 (14.6%) 12 (16.4%) 1.00
Fibronodular infiltration 26 (54.2%) 44 (60.3%) .574
Alveolar consolidation 14 (29.2%) 23 (31.5%) .842
Diffuse nodule or mass 4 (8.4%) 6 (8.2%) 1.00
Echoic features by EBUS
Presence of air bronchogram NA 54 (74.0%) NA
Continuous margin NA 41 (56.1%) NA
Homogenous echogenicity NA 53 (72.5%) NA
Chronic coexisting condition
Diabetes mellitus 8 (16.7%) 20 (27.4%) .193
Hypertension 6 (12.5%) 12 (16.4%) .611
Chronic renal insufficiency 2 (4.2%) 7 (9.6%) .316
Cancer 1 (2.1%) 4 (5.5%) .647
Chronic obstructive pulmonary disease 3 (6.3%) 4 (5.5%) 1.00
Previous tuberculosis infection 2 (4.2%) 4 (5.5%) 1.00
Values are presented as numbers (percentages), where shown. EBUS, Endobronchial ultrasonography; SD, standard deviation; NA, not available.P
M(72.5%) of 73 patients, respectively. Diabetes mellitus was
the most frequent chronic comorbidity in both groups. There
were no cancers diagnosed in the study population.
Yields of Sputum and Lavaged Specimens for
Tuberculosis Diagnosis
Thirty-six (49.3%) of 73 patients in the EBUS group and
18 (37.5%) of 48 patients undergoing conventional
bronchoscopy had no spontaneous sputum, whereas 37
(50.7%) of 73 patients in the EBUS group and 30 (62.5%)
of 48 patients undergoing conventional bronchoscopy had
negative AFB smears in 3 consecutive daily sputum
specimens. The diagnostic yields of AFB smears in BALF
(31.5% [23/73], P ¼ .018), M tuberculosis in BALF
(67.1% [49/73], P ¼ .04), and histologic diagnosis ofThe Journal of Thoracic and Ctuberculosis by means of TBLB (32.9% [24/73], P< .001)
were significantly higher in patients undergoing EBUS.
There were 12.5% (6/48), 47.9% (23/48), and 4.2% (2/48)
patients who underwent conventional bronchoscopy, respec-
tively (Table 2).With the aid of EBUS, the overall diagnostic
yield for tuberculosis bymeans of bronchoscopic procedures
(smears and cultures of BALF and TBLB specimens) was
higher (80.8%) than that for those who did not undergo
EBUS (58.3%, P ¼ .035; Table 2).
Yields of Lavaged Specimens for Tuberculosis
Diagnosis Stratified by Size of Lesion
In patients with lesions smaller than 3 cm (Table 3), bron-
choscopy with EBUS (n ¼ 31) produced higher diagnostic
yields of AFB smears in BALF (35.5% vs 4.5%,TABLE 2. Yield of sputum and EBUS-guided bronchial lavage smear, culture, and biopsy results for the diagnosis of tuberculosis
Result Without EBUS* With EBUS* P value
Positive sputum culture 18/30 (60%) 12/37 (32.4%) .029
Positive BALF smear 6/48 (12.5%) 23/73 (31.5%) .018
Positive BALF culture 23/48 (47.9%) 49/73 (67.1%) .040
Positive TBLB 2/48 (4.2%) 24/73 (32.9%) <.0001
Positive BALF smear, culture, or TBLB specimen 29/48 (60.4%) 59/73 (80.8%) .020
EBUS, Endobronchial ultrasonography; BALF, bronchoalveolar lavage fluid; TBLB, transbronchial lung biopsy. *Positive sample number/total sample number.ardiovascular Surgery c Volume 138, Number 1 181
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(n ¼ 42) P value
Positive BALF smear 1 (4.5%) 11 (35.5%) .009 5 (22.7%) 12 (28.6%) .565
Positive BALF culture 6 (27.3%) 19 (61.3%) .025 17 (77.3%) 30 (71.4%) .602
Positive TBLB 1 (4.5%) 10 (32.3%) .017 1 (4.5%) 14 (33.3%) .006
Positive BALF smear, culture, or
TBLB specimen
7 (31.8%) 25 (80.6%) .0005 21 (80.7%) 24 (80.9%) 1.00
EBUS, Endobronchial ultrasonography; BALF, bronchoalveolar lavage fluid; TBLB, transbronchial lung biopsy.P ¼ .009),M tuberculosis in BALF (61.3% vs 27.3%, P ¼
.025), and pathologic reports of tuberculosis diagnosis in
TBLB specimens (32.3% vs 4.5%, P ¼ .017) than conven-
tional bronchoscopy (n ¼ 22). With the aid of EBUS, the
overall diagnostic yield for tuberculosis by using broncho-
scopic procedures was higher (80.6%) than that for those
who did not undergo EBUS (31.8%, P¼ .0005). In patients
with lesions larger than 3 cm in size, bronchoscopy with
EBUS (n ¼ 42) produced higher diagnostic yields of patho-
logic reports of tuberculosis in TBLB specimens (33.3% vs
4.5%, P ¼ .006) but similar yields of AFB smears in BALF
(28.6% vs 22.7%, P ¼ .565), M tuberculosis in BALF
(71.4% vs 77.3%, P ¼ .602), and overall diagnosis for
tuberculosis (80.9% vs 80.7%, P¼ 1.00) by using broncho-
scopic procedures compared with conventional bronchos-
copy (n ¼ 26).
First Results for Diagnosis of Pulmonary
Tuberculosis
Table 4 summarizes the first available results for initial di-
agnosis of pulmonary tuberculosis in the sputum-negative
patients. There was a higher proportion of patients in the
EBUS group initially documented to have pulmonary tuber-
culosis based on positive AFB smears of BALF (31.5%
[n ¼ 23], P ¼ .018) and histologic diagnosis of tuberculosis
by using TBLB (24.7% [n¼ 18], P¼ .003) when compared
with those in the conventional bronchoscopy group (12.5%
[n ¼ 6] and 4.2% [n ¼ 2], respectively; Figure 1). There
was a higher proportion of patients in the conventional group
with tuberculosis diagnosis documented only by positive182 The Journal of Thoracic and Cardiovascular Surculture (70.8%, either from BALF or sputum) than among
patients undergoing EBUS (27.4%, P< .001; Table 3; Fig-
ure 1). With the aid of EBUS, the first available results from
bronchoscopy-guided procedures documented tuberculosis
in 59 (23 patients based on BALF smears, 18 patients based
on BALF cultures, and 18 patients based on TBLB speci-
mens) of 73 patients, with only 28 (6 patients based on
BALF smears, 20 patients based on BALF cultures, and 2
patients based on TBLB specimens) of 48 patients undergo-
ing conventional bronchoscopy (80.8% vs 58.3%, P ¼
.035). For those patients with negative results with broncho-
scopic procedures, 2 (2.7%) of the 73 patients undergoing
EBUS and 14 (29.2%) of 48 patients not undergoing
EBUS were given diagnoses based on positive sputumM tu-
berculosis cultures. CT-guided biopsy was required for the
diagnosis of tuberculosis in 6 (12.5%) of 48 patients in
the conventional group and 12 (16.4%) of 72 patients in
the EBUS group.
Treatment of Pulmonary Tuberculosis
The time to diagnosis of tuberculosis in patients undergo-
ing EBUS (23.1  16.7 days) was shorter than that in pa-
tients undergoing conventional bronchoscopy (32.4  25.7
days, P ¼ .017). Similarly, the time to initiate treatment in
patients receiving conventional bronchoscopy (39.7 
25.8 days) was longer than that in patients receiving bron-
choscopy with EBUS (29.4  17.1 days, P ¼ .009). How-
ever, the EBUS group (58/73 [79%]) had a similar rate of
complete tuberculosis treatment when compared with the
conventional group (35/48 [73%], P ¼ .404).TABLE 4. The first available study results for clinical diagnosis of pulmonary tuberculosis
Diagnosis established based on: Without EBUS (n ¼ 48) With EBUS (n ¼ 73) P value
Positive BALF smear 6 (12.5%) 23 (31.5%) .018
Positive BALF and sputum culture 4 (8.3%) 4 (5.5%) .711
Positive BALF but negative sputum culture 16 (33.3%) 14 (21.9%) .089
Positive sputum but negative BALF culture 14 (29.2%) 2 (2.7%) <.0001
Positive TBLB specimen 2 (4.2%) 18 (24.7%) .003
CT-guided biopsy 6 (12.5%) 12 (16.4%) .611
Positive BALF smear or TBLB specimen 8 (16.7%) 41 (56.2%) <.0001
Only culture positive 34 (70.8%) 20 (27.4%) <.0001
Positive lavage smear, culture, or biopsy specimen 28 (58.3%) 59 (80.8%) .035
EBUS, Endobronchial ultrasonography; BALF, bronchoalveolar lavage fluid; TBLB, transbronchial lung biopsy; CT, computed tomography.gery c July 2009
Lin et al Perioperative ManagementFIGURE 1. Analysis of the first available results for diagnosis of pulmonary tuberculosis. EBUS, Endobronchial ultrasonography; CT, computed tomog-
raphy; BALF, bronchoalveolar lavage fluid; TBLB, transbronchial lung biopsy.P
MComplications
Pneumothorax occurred in 1 (1.0%) patient after the
EBUS procedure and resolved spontaneously, but no pneu-
mothorax developed in the conventional bronchoscopy
group. No major bleeding with hemodynamic instability de-
veloped during the procedure in either group.
DISCUSSION
In patients who are suspected of having tuberculosis for
radiologic reasons but with negative sputum AFB smears
or no sputum production, the introduction of EBUS has
been shown in this report to increase the diagnostic yields
for tuberculosis by bronchoscopy-related procedures, in-
cluding AFB smears and M tuberculosis cultures from
BALF, and pathologic documentation by TBLB. Combin-
ing AFB smears of BALF and pathology by TBLB, bron-
choscopy with EBUS could achieve a higher rate of rapid
diagnosis of tuberculosis than conventional bronchoscopy.
The negative sputum smear and a lack of spontaneous spu-
tum in patients with pulmonary tuberculosis have been re-
ported to be the major causes of treatment delay for
tuberculosis.16 Fiberoptic bronchoscopy has been used for
obtaining lower respiratory tract sections and lung tissue in
those patients to avoid a delay in treatment.3 The diagnosticThe Journal of Thoracic and Cyield for pulmonary tuberculosis of BALF in patients with
negative sputum smears has been demonstrated with varying
results, ranging from 7.5% to 24% for smears and 15% to
67.4% for cultures.3,6-8 The wide range of variability in con-
ventional bronchoscopy might be due to the lesions that
could not be seen with conventional bronchoscopy.17 Once
the lesion is not visible with conventional bronchoscopy,
bronchoalveolar lavage and TBLB are performed in a best-
guess fashion orwith the aid of a fluoroscope.18 In the present
study our diagnostic yield of conventional bronchoscopy for
pulmonary tuberculosis (58.3%) was in line with that seen in
previous reports. In the lesions that are not visualized with
conventional bronchoscopy, EBUS images allow confirma-
tion of the precise location of lesions bymeans of direct visu-
alization. Therefore with the aid of EBUS to accurately
localize the lesion, bronchoscopy-related procedures, espe-
cially bronchoalveolar lavage and TBLB, increased the over-
all diagnostic yield for pulmonary tuberculosis to more than
80%. In addition, the use of EBUS during bronchoscopic
procedures did not increase the risk for pneumothorax. The
incidence of pneumothorax in our study is in line with that
seen in previous reports, approximately 1%.19,20
The image characteristics of EBUS provide clues in deter-
mining the nature of peripheral abnormalities, such asardiovascular Surgery c Volume 138, Number 1 183
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ultrasonic features.21 A previous report has correlated histo-
pathologic findings from surgical specimens to develop
a classification system of sonographic images to distinguish
between benign and malignant lesions.21 Our previous study
also indicates that with 3 image patterns, including the pres-
ence of continuous margin, absence of a linear discrete air
bronchogram, and heterogenous echogenicity of the internal
structure, EBUS provides a useful tool for differentiating be-
nign lesions frommalignancy in peripheral lung lesions.11 In
the present study the EBUS image pattern of pulmonary tu-
berculosis showed a high percentage of benign characteristic
features, including the presence of an air bronchogram and
homogenous echogenicity. Thus apart from its role in im-
proving the diagnostic yield for pulmonary tuberculosis,
the EBUS image pattern of pulmonary tuberculosis lesions
might offer clues for differentiating benign lesions from ma-
lignant peripheral lung lesions.
Rapid diagnosis and treatment have long been considered
a crucial factor for better outcome of patients with tubercu-
losis.2,5,15,16 In this study AFB smears of BALF and pathol-
ogy by TBLB specimens offered rapid evidence for
tuberculosis infection in more 50% of the patients in the
EBUS group but only 16.7% of the patients receiving con-
ventional bronchoscopy. The high diagnostic yield of
EBUS-guided bronchoscopy for early diagnosis of tubercu-
losis infection might therefore avoid a delay in administra-
tion of antituberculosis treatment or the need for further
invasive procedures, such as CT-guided or surgical biopsy,
to reach a definite diagnosis. However, a false-positive result
on a BALF smear can occur, and therefore M tuberculosis
culture in BALF is still required for a definite diagnosis.
Several limitations of this study warrant mention. First, this
is a retrospective studywith all the patientswith pulmonary tu-
berculosis, and therefore the sensitivity, specificity, and pre-
dictive value cannot be determined. In addition, the study
recruited patientswith negativeAFBsmears or no sputumpro-
duction. Therefore the results of our study could not be ex-
tended to all the patients with suspicious tuberculosis lesions.
In conclusion, sputum AFB smears and M tuberculosis
cultures should be first performed in patients under
suspicion of pulmonary tuberculosis. Once bronchoscopy
is arranged to obtain lower airway secretion for documen-
tation of pulmonary tuberculosis in patients with negative
sputum smears or no sputum production, EBUS-guided
bronchoscopic procedures can provide higher diagnostic
yield and rapid diagnosis.184 The Journal of Thoracic and Cardiovascular SurReferences
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